How to Fix Life Science Go-to-Market Gaps in 2026
By Matt Wilkinson
Nobody Has a Formula for Your Portfolio Split
By Jasmine Gruia-Gray
Your strategy was right but organisational gravity still struck
By Matt Wilkinson
When Agile Beats Stage-Gate: The Line Extension Case
By Jasmine Gruia-Gray
AI persona tools for life sciences, compared
By Matt Wilkinson
Marketing's seventh wave has a buyer problem
By Matt Wilkinson
Stage-Gate's Eight Advances, and the Two Most Teams Use
By Jasmine Gruia-Gray
Your team is botsitting, here is the bill
By Matt Wilkinson
Your portfolio revenue stopped telling you the truth
By Jasmine Gruia-Gray
A Brand is trust and AI slop can break it fast
By Matt Wilkinson
When to walk away: kill the business case or just table it
By Jasmine Gruia-Gray
Your audience poll came back split - read who is hiding in the tie
By Matt Wilkinson
The Fever Your Competitor Stopped Feeling: A Practical Guide to Displacing an Incumbent Vendor
By Jasmine Gruia-Gray
I ran an AI SEO audit on my own site
By Matt Wilkinson
Stage Gates Should Ask for Evidence, Not Optimism
By Jasmine Gruia-Gray